SUN PHARMA ADVANCED RESEARCH COMPANY
|
The Current P/S Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 3.31.
| Share Price | ₹194.8 | Aug 27,2026 |
| Market Cap | ₹6,319.6 Cr | |
| Sales-TTM | ₹1,909.5 Cr | TTM-Consolidated Results |
| Price/Sales | 3.31x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹6,319.6 Cr] as on Aug 27,2026
(/) Sales [ ₹1,909.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.31x ]
Thus, for SUN PHARMA ADVANCED RESEARCH COMPANY , the investors are currently willing to pay '3.31 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUN PHARMA ADVANCED RESEARCH COMPANY !
The chart below summarizes the trend in P/S Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY over the last five years.
Historical PS (Price/Sales) ratio chart of SUN PHARMA ADVANCED RESEARCH COMPANY
PS Ratio Performance Analysis for SUN PHARMA ADVANCED RESEARCH COMPANY
- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio for fiscal years ending Mar2026 to Mar2023 averaged 63.06x.
- SUN PHARMA ADVANCED RESEARCH COMPANY 's operated at median p/e ratio of 66.93x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio peaked in Mar2024 at 158.92x.
- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio hit its five-year low in Mar2026 of 1.98x.
How does SUN PHARMA ADVANCED RESEARCH COMPANY 's P/S Ratio benchmark against top 10 peers in Business Support Industry?
| Peer Comparison (Business Support Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SUN PHARMA ADVANCED RESEARCH COMPANY | 1,909.5 | 3.31 | 6,319.6 |
| SAGILITY LTD | 7,617.4 | 2.67 | 20,321.7 |
| SYNGENE INTERNATIONAL LTD | 3,600.2 | 4.64 | 16,709.9 |
| PRIME FOCUS LTD | 4,919.5 | 4.66 | 22,915.4 |
| INTERNATIONAL GEMOLOGICAL INSTITUTE LTD | 1,070.3 | 13.86 | 14,831.7 |
| INDEGENE LTD | 3,812.8 | 3.58 | 13,665.8 |
| NESCO LTD | 932.1 | 7.69 | 7,171.4 |
| LATENT VIEW ANALYTICS LTD | 1,111.1 | 5.13 | 5,695.6 |
| CMS INFO SYSTEMS LTD | 2,494.5 | 1.54 | 3,847.1 |
| SMARTWORKS COWORKING SPACES LTD | 1,962.8 | 3.15 | 6,180.0 |
| JUST DIAL LTD | 1,243.5 | 4.38 | 5,448.2 |
Business Support Industry Benchmark (Top 10) PS Analysis vs SUN PHARMA ADVANCED RESEARCH COMPANY 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.54x |
| Max industry PS | 13.86x |
| Median industry PS | 4.38x |
| Average industry PS | 4.96x |
You may also like the below Video Courses